Sharechat Logo

Double blow for A2 Corporation

Friday 4th July 2003

Text too small?
Controversial milk company A2 Corporation has suffered a double blow with the death of one director and the severe illness of another.

Chairman Jim Guthrie said from Dunedin yesterday that the death on Monday of director and significant shareholder Howard Paterson follows closely after the cancer diagnosis and subsequent treatment of founder Dr Corran McLachlan.

"Directors, shareholders and staff are devastated by Howard's sudden death," he said.

"Corrie is undergoing treatment and is not expected to be on deck for some time."

Mr Guthrie said the best way they could "keep faith with the vision of Mr Paterson and Dr McLachlan was to continue with the work they began."

Mr Guthrie said A2 Corporation's European directors would be travelling to New Zealand shortly to help the board review the company's future options.

"We are fortunate that we can call on the services of some very talented people here and overseas," he said. "Despite these recent tragic occurrences A2 Corporation is strongly positioned to build upon the foundation laid down by Howard and Corrie."

A2 Corporation was founded in 2000 to commercialise research relating to milk proteins. Its licensees have recently released a range of milk products on the New Zealand and Australian markets.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

PaySauce Quarterly Market Update - Dec 2024
CHI - FY24 Results Date and Audio Conference Details
AIA - December 2024 Monthly traffic update
January 15th Morning Report
PF - Details of Interim Results Webcast
Scott Secures NZ$18 million in Global Contracts for Protein
January 14th Morning Report
AFT - NEW YEAR LETTER TO INVESTORS
TruScreen Invited to Present WHO AI Collaboration Meeting
January 13th Morning Report